These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23250801)

  • 1. Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study.
    Jensen MK; Bartz TM; Mukamal KJ; Djoussé L; Kizer JR; Tracy RP; Zieman SJ; Rimm EB; Siscovick DS; Shlipak M; Ix JH
    Diabetes Care; 2013 May; 36(5):1222-8. PubMed ID: 23250801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study.
    Ix JH; Biggs ML; Mukamal KJ; Kizer JR; Zieman SJ; Siscovick DS; Mozzaffarian D; Jensen MK; Nelson L; Ruderman N; Djousse L
    Circulation; 2012 May; 125(19):2316-22. PubMed ID: 22511752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
    Aroner SA; St-Jules DE; Mukamal KJ; Katz R; Shlipak MG; Criqui MH; Kestenbaum B; Siscovick DS; de Boer IH; Jenny NS; Budoff MJ; Ix JH; Jensen MK
    Atherosclerosis; 2016 May; 248():224-9. PubMed ID: 27038419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study.
    Laughlin GA; Cummins KM; Wassel CL; Daniels LB; Ix JH
    J Am Coll Cardiol; 2012 May; 59(19):1688-96. PubMed ID: 22554599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetuin-A and incident diabetes mellitus in older persons.
    Ix JH; Wassel CL; Kanaya AM; Vittinghoff E; Johnson KC; Koster A; Cauley JA; Harris TB; Cummings SR; Shlipak MG;
    JAMA; 2008 Jul; 300(2):182-8. PubMed ID: 18612115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study.
    Ix JH; Barrett-Connor E; Wassel CL; Cummins K; Bergstrom J; Daniels LB; Laughlin GA
    J Am Coll Cardiol; 2011 Nov; 58(23):2372-9. PubMed ID: 22115642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study.
    Laughlin GA; Barrett-Connor E; Cummins KM; Daniels LB; Wassel CL; Ix JH
    Diabetes Care; 2013 Jul; 36(7):1994-2000. PubMed ID: 23315604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
    Bostom A; Pasch A; Madsen T; Roberts MB; Franceschini N; Steubl D; Garimella PS; Ix JH; Tuttle KR; Ivanova A; Shireman T; Gohh R; Merhi B; Jarolim P; Kusek JW; Pfeffer MA; Liu S; Eaton CB
    Am J Nephrol; 2018; 48(1):21-31. PubMed ID: 29996127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.
    Roos M; Oikonomou D; von Eynatten M; Luppa PB; Heemann U; Lutz J; Baumann M; Nawroth PP; Bierhaus A; Humpert PM
    Cardiovasc Diabetol; 2010 Sep; 9():48. PubMed ID: 20822519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in cardiovascular risk factors before and after the development of type 2 diabetes and risk for incident cardiovascular disease.
    Bancks MP; Akhabue E; Rana JS; Reis JP; Schreiner PJ; Yano Y; Lewis CE
    Diabetes Res Clin Pract; 2020 Aug; 166():108334. PubMed ID: 32702469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
    Hanssen NMJ; Westerink J; Scheijen JLJM; van der Graaf Y; Stehouwer CDA; Schalkwijk CG;
    Diabetes Care; 2018 Aug; 41(8):1689-1695. PubMed ID: 29784769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Body Mass Index with the Risk of Incident Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality: A Community-Based Prospective Study.
    Bae JC; Cho NH; Kim JH; Hur KY; Jin SM; Lee MK
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):416-424. PubMed ID: 32615726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.
    Bonora E; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Cacciatori V; Santi L; Targher G; Bonadonna R; Muggeo M
    Diabetes Care; 2002 Jul; 25(7):1135-41. PubMed ID: 12087010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL).
    Hanssen NM; Beulens JW; van Dieren S; Scheijen JL; van der A DL; Spijkerman AM; van der Schouw YT; Stehouwer CD; Schalkwijk CG
    Diabetes; 2015 Jan; 64(1):257-65. PubMed ID: 24848072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study.
    Morling JR; Fallowfield JA; Williamson RM; Robertson CM; Glancy S; Guha IN; Strachan MW; Price JF
    Diabetologia; 2015 Jul; 58(7):1484-93. PubMed ID: 25820150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet Quality and Cardiovascular Disease Risk in Postmenopausal Women With Type 2 Diabetes Mellitus: The Women's Health Initiative.
    Hirahatake KM; Jiang L; Wong ND; Shikany JM; Eaton CB; Allison MA; Martin L; Garcia L; Zaslavsky O; Odegaard AO
    J Am Heart Assoc; 2019 Oct; 8(19):e013249. PubMed ID: 31533514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.
    Nelson TL; Biggs ML; Kizer JR; Cushman M; Hokanson JE; Furberg CD; Mukamal KJ
    J Clin Endocrinol Metab; 2012 May; 97(5):1695-701. PubMed ID: 22399516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.
    Hanley AJ; Williams K; Stern MP; Haffner SM
    Diabetes Care; 2002 Jul; 25(7):1177-84. PubMed ID: 12087016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
    Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.